Live Quote · NASDAQTMCIHealthcare· Medical - Devices

Treace Medical Concepts, Inc.

$4.21 0.47%($-0.02)
TickerSpark Score
60/100
Mixed
75
Valuation
40
Profitability
30
Growth
76
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMCI research report →

52-Week Range46% of range
Low
$1.17
Current
$4.21
High
$7.78
Company Overviewwww.treace.com

About the company

Treace Medical Concepts, Inc. , a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.

CEO
John T. Treace
IPO
2021
Employees
432
HQ
Ponte Vedra, FL, US

Price Chart

-30.87% · this period
$7.70$4.45$1.20Jul 02Dec 31Jul 02
Valuation
Market Cap
$273.12M
P/E
-4.34
P/S
1.32
P/B
3.52
EV/EBITDA
-5.98
Div Yield
0.00%
Profitability
Gross Margin
79.72%
Op Margin
-26.89%
Net Margin
-29.44%
ROE
-69.50%
ROIC
-37.26%
Growth & Income
Revenue
$212.69M · 1.59%
Net Income
$-59,002,000 · -5.85%
EPS
$-0.93 · -3.33%
Op Income
$-54,154,000
FCF YoY
39.53%
Performance & Tape
52W High
$7.78
52W Low
$1.17
50D MA
$3.09
200D MA
$3.27
Beta
1.41
Avg Volume
925.26K

Get TickerSpark's AI analysis on TMCI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 11, 26Treace John T.buy9,891
Jun 10, 26Treace John T.buy14,715
Jun 11, 26Treace John T.buy22,887
Jun 10, 26Treace John T.buy29,430
Jun 1, 26Treace John T.buy50,000
May 28, 26Treace John T.buy61,202
May 27, 26Treace John T.buy49,810
May 26, 26Treace John T.buy4,508
May 19, 26BAKEWELL JOHN Kother30,000
May 19, 26Kiernan Jane Eother30,000
Coverage · TMCI

Our TMCI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on TMCI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate TMCI report →
Internal Compare

Similar companies

Peers in the same neighborhood.